Related Experiment Video
Updated: Jan 18, 2026
11:23
An Open-Source Normothermic Perfusion System Designed for Research Scientists
Published on: July 18, 2025
1.1K
Optimizing standardized neonatal and infant continuous infusion concentrations based on intravenous infusion pump
Adam C Moss1, Kathryn A Morbitzer2, Stephen F Eckel2,3
1HCA Healthcare, Nashville, TN, USA.
Summary
Optimizing standardized medication concentrations for neonatal and infant continuous infusions enhances patient safety. This study developed a framework for optimal concentrations and syringe sizes, reducing medication errors in pediatric care.
Area of Science:
- Pediatric Pharmacology
- Neonatal Intensive Care
- Medication Safety Engineering
Background:
- Continuous infusions are critical in neonatal and infant care.
- Variability in medication concentrations poses risks for pediatric patients.
- Standardization efforts are needed to improve medication safety.
Purpose of the Study:
- To optimize standardized concentrations for neonatal and infant continuous infusions.
- To enhance patient safety and reduce medication errors in pediatric care.
- To develop a framework for optimal concentrations and syringe sizes.
Main Methods:
- Focus groups with pediatric and neonatal healthcare professionals identified best practices.
- Analysis of 12 months of utilization data from syringe infusion pumps for infants under 10 kg.
- Optimization of concentrations based on fluid percentage, syringe exchanges, and infusion rates.
Main Results:
- 4,179 administrations were analyzed after applying exclusion criteria.
- Modifications to concentrations and syringe sizes were recommended for 9 out of 17 medications.
- Optimized concentrations and syringe sizes improved infusion practices and reduced potential errors, exemplified by furosemide adjustments.
Conclusions:
- Significant opportunities exist for optimizing standardized concentrations in neonatal and infant care.
- The developed methodology provides a foundation for national standardization of infusion practices.
- Further research integrating broader data and advanced technologies can further enhance pediatric medication safety.
Related Concept Videos
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
238
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
238
01:09One-Compartment Model: IV Infusion
494
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
494
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
233
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
233
01:29Drug Dosing: Infants and Children
257
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
258
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258